Last reviewed · How we verify
NCT05978921
Physical Exercise in Patients With Schizophrenia
NA trial testing Strength physical exercise programme in Schizophrenia in 40 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | University of Salamanca |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 40 |
| Start date | 1 March 2024 |
| Primary completion | 1 April 2024 |
| Estimated completion | 1 May 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Strength physical exercise programme
- Normal life
Conditions studied
- Schizophrenia — all drugs for Schizophrenia →
- Physical Activity — all drugs for Physical Activity →
- Telomere Shortening — all drugs for Telomere Shortening →
- Premature Aging — all drugs for Premature Aging →
Sponsor
University of Salamanca
Who can join
Adults 18 to 80, any sex, with Schizophrenia or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomised clinical trial on a cohort of subjects with a diagnosis of schizophrenia of legal age, of both sexes, recruited in the mental health clinics of the Salamanca University Assistance Complex and who will be randomly distributed into two groups (intervention and control). The main objective of the study is to determine the effect of physical exercise on telomere size in patients diagnosed with schizophrenia. As secondary objectives in this group of patients we will try to: Evaluate the influence of strength training on cognition and negative symptoms of schizophrenia. To quantify the impact of strength training on frailty. To determine the effect of strength training on quality of life. To study the possible correlation between physical parameters (frailty) and telomere length. To establish the importance of polymorphisms in telomerase genes, an enzyme involved in the maintenance of telomere length.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of strength-based physical exercise on telomere length as a marker of premature ageing in patients with schizophrenia: study protocol for a pilot randomised controlled trial.
Sánchez-González JL, Juárez-Vela R, Dutil Muñoz de la Torre V, Andrés-Olivera MDP, et al · · 2024 · PMID 39324245 · DOI 10.1192/bjo.2024.753
Verify or expand the search:
- PubMed search for NCT05978921
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Schizophrenia
Currently open trials in the same condition.
- NCT07424404 — A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au · Phase 3 · recruiting
- NCT07467993 — Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia · Phase 2 · recruiting
- NCT07379827 — Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · recruiting
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
Other University of Salamanca trials
Trials by the same sponsor.
- NCT07359495 — Multicomponent Training and Muscle Quality in Older Women · NA · not yet recruiting
- NCT07286539 — Precision Physical Exercise for Personalized Onco-Hematology. · NA · not yet recruiting
- NCT07387770 — Muscle Deterioration in Hospitalized Cancer Patient · NA · not yet recruiting
- NCT07387757 — Exergames in Mental Health · NA · not yet recruiting
- NCT07333768 — EQUISOCK: New Antiequine · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05978921 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Salamanca
- Last refreshed: 22 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05978921.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing